Compare $CLRB vs $GTBP | Chartloom

Compare

$CLRB vs $GTBP

Cellectar Biosciences Inc · GT Biopharma Inc

CLRB

Cellectar Biosciences Inc

GTBP

GT Biopharma Inc

Compare $CLRB vs $GTBP

Comparing Cellectar Biosciences Inc and GT Biopharma Inc

CLRBCellectar Biosciences Inc

GTBPGT Biopharma Inc

CLRBCellectar Biosciences Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-58.2%

52W performance

-69.7%

FCF yield

-168.2%

GTBPGT Biopharma Inc

Market cap

$296M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-75.3%

FCF yield

-4.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLRB

GTBP

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

GTBP

GT Biopharma Inc

Market Cap

CLRB$12M

GTBP$296M

Enterprise Value

CLRB$-22M

GTBP$291M

Price

CLRB$1.45

GTBP$6.68

P/E Ratio

CLRBN/A

GTBPN/A

P/S Ratio

CLRB186.94x

GTBP174.71x

EV/Sales

CLRB-190.77x

GTBP95.98x

EV/EBITDA

CLRB0.00x

GTBP0.00x

P/B Ratio

CLRB0.56x

GTBP3.08x

P/FCF Ratio

CLRBN/A

GTBPN/A

EV/FCF

CLRB1.15x

GTBP-20.19x

PEG Ratio

CLRBN/A

GTBPN/A

Forward P/E (NTM)

CLRBN/A

GTBPN/A

Forward P/S (NTM)

CLRBN/A

GTBPN/A

Revenue (TTM)

CLRB$0

GTBP$0

Revenue Growth (YoY)

CLRBN/A

GTBPN/A

Forward Rev Growth

CLRB585.7%

GTBP216.5%

Gross Margin (TTM)

CLRB0.0%

GTBP36.5%

Operating Margin (TTM)

CLRB0.0%

GTBP0.0%

EBITDA Margin (TTM)

CLRB0.0%

GTBP0.0%

Net Margin (TTM)

CLRB0.0%

GTBP0.0%

FCF Margin (TTM)

CLRBN/A

GTBPN/A

Net Income (TTM)

CLRB$-22M

GTBP$-33M

FCF (TTM)

CLRB$-19M

GTBP$-14M

EPS (TTM)

CLRB-$1.83

GTBP-$21.10

ROE (TTM)

CLRB-16571.0%

GTBP-44308.0%

ROA (TTM)

CLRB-11542.0%

GTBP-31311.0%

ROIC (TTM)

CLRB-16571.0%

GTBP-44308.0%

Cash

CLRB$34M

GTBP$5M

Debt

CLRB$0

GTBP$0

Net Cash/Debt

CLRB$34M

GTBP$5M

Current Ratio (TTM)

CLRB6.66x

GTBP2.61x

Quick Ratio (TTM)

CLRB6.49x

GTBP2.51x

Debt/Equity (TTM)

CLRB0.00x

GTBP0.00x

Debt/Assets (TTM)

CLRB0.0%

GTBP0.0%

Interest Coverage (TTM)

CLRBN/A

GTBPN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

GTBP0.00x

Beta

CLRB0.58

GTBP0.81

52W Performance

CLRB-69.7%

GTBP-75.3%

YTD Performance

CLRB-58.2%

GTBP-67.3%

% from 52W High

CLRB-71.4%

GTBP-76.8%

% from 52W Low

CLRB8.2%

GTBP36.0%

Asset Turnover (TTM)

CLRB0.01x

GTBP0.08x

FCF Yield (TTM)

CLRB-168.2%

GTBP-4.9%

Earnings Yield (TTM)

CLRB-192.7%

GTBP-11.1%

Dividend Yield (TTM)

CLRBN/A

GTBPN/A

Rule of 40

CLRB0.0

GTBP0.0

EV/GP/RG

CLRBN/A

GTBPN/A

Ticker research

View CLRB research View GTBP research

Metric	CLRB Cellectar Biosciences Inc	GTBP GT Biopharma Inc
Market & Valuation
Market Cap	$12M	$296M
Enterprise Value	$-22M	$291M
Price	$1.45	$6.68
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	174.71x
EV/Sales	-190.77x	95.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	3.08x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	-20.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	216.5%
Profitability
Gross Margin (TTM)	0.0%	36.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-33M
FCF (TTM)	$-19M	$-14M
EPS (TTM)	-$1.83	-$21.10
ROE (TTM)	-16571.0%	-44308.0%
ROA (TTM)	-11542.0%	-31311.0%
ROIC (TTM)	-16571.0%	-44308.0%
Financial Health
Cash	$34M	$5M
Debt	$0	$0
Net Cash/Debt	$34M	$5M
Current Ratio (TTM)	6.66x	2.61x
Quick Ratio (TTM)	6.49x	2.51x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.81
52W Performance	-69.7%	-75.3%
YTD Performance	-58.2%	-67.3%
% from 52W High	-71.4%	-76.8%
% from 52W Low	8.2%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.08x
FCF Yield (TTM)	-168.2%	-4.9%
Earnings Yield (TTM)	-192.7%	-11.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View GTBP research

Valuation

P/S Ratio

GTBP

174.71x

CLRB

186.94x

EV/FCF

GTBP

-20.19x

CLRB

1.15x

Growth & revenue

Forward Revenue Growth

CLRB

585.7%

GTBP

216.5%

Profitability & performance

Gross Margin

GTBP

36.5%

CLRB

0.0%

ROE

CLRB

-16571.0%

GTBP

-44308.0%

FCF Yield %

GTBP

-4.9%

CLRB

-168.2%

52-Week Performance

CLRB

-69.7%

GTBP

-75.3%

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

GTBP

GT Biopharma Inc

Market Cap

CLRB$12M

GTBP$296M

Enterprise Value

CLRB$-22M

GTBP$291M

Price

CLRB$1.45

GTBP$6.68

P/E Ratio

CLRBN/A

GTBPN/A

P/S Ratio

CLRB186.94x

GTBP174.71x

EV/Sales

CLRB-190.77x

GTBP95.98x

EV/EBITDA

CLRB0.00x

GTBP0.00x

P/B Ratio

CLRB0.56x

GTBP3.08x

P/FCF Ratio

CLRBN/A

GTBPN/A

EV/FCF

CLRB1.15x

GTBP-20.19x

PEG Ratio

CLRBN/A

GTBPN/A

Forward P/E (NTM)

CLRBN/A

GTBPN/A

Forward P/S (NTM)

CLRBN/A

GTBPN/A

Revenue (TTM)

CLRB$0

GTBP$0

Revenue Growth (YoY)

CLRBN/A

GTBPN/A

Forward Rev Growth

CLRB585.7%

GTBP216.5%

Gross Margin (TTM)

CLRB0.0%

GTBP36.5%

Operating Margin (TTM)

CLRB0.0%

GTBP0.0%

EBITDA Margin (TTM)

CLRB0.0%

GTBP0.0%

Net Margin (TTM)

CLRB0.0%

GTBP0.0%

FCF Margin (TTM)

CLRBN/A

GTBPN/A

Net Income (TTM)

CLRB$-22M

GTBP$-33M

FCF (TTM)

CLRB$-19M

GTBP$-14M

EPS (TTM)

CLRB-$1.83

GTBP-$21.10

ROE (TTM)

CLRB-16571.0%

GTBP-44308.0%

ROA (TTM)

CLRB-11542.0%

GTBP-31311.0%

ROIC (TTM)

CLRB-16571.0%

GTBP-44308.0%

Cash

CLRB$34M

GTBP$5M

Debt

CLRB$0

GTBP$0

Net Cash/Debt

CLRB$34M

GTBP$5M

Current Ratio (TTM)

CLRB6.66x

GTBP2.61x

Quick Ratio (TTM)

CLRB6.49x

GTBP2.51x

Debt/Equity (TTM)

CLRB0.00x

GTBP0.00x

Debt/Assets (TTM)

CLRB0.0%

GTBP0.0%

Interest Coverage (TTM)

CLRBN/A

GTBPN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

GTBP0.00x

Beta

CLRB0.58

GTBP0.81

52W Performance

CLRB-69.7%

GTBP-75.3%

YTD Performance

CLRB-58.2%

GTBP-67.3%

% from 52W High

CLRB-71.4%

GTBP-76.8%

% from 52W Low

CLRB8.2%

GTBP36.0%

Asset Turnover (TTM)

CLRB0.01x

GTBP0.08x

FCF Yield (TTM)

CLRB-168.2%

GTBP-4.9%

Earnings Yield (TTM)

CLRB-192.7%

GTBP-11.1%

Dividend Yield (TTM)

CLRBN/A

GTBPN/A

Rule of 40

CLRB0.0

GTBP0.0

EV/GP/RG

CLRBN/A

GTBPN/A

Ticker research

View CLRB research View GTBP research

Metric	CLRB Cellectar Biosciences Inc	GTBP GT Biopharma Inc
Market & Valuation
Market Cap	$12M	$296M
Enterprise Value	$-22M	$291M
Price	$1.45	$6.68
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	174.71x
EV/Sales	-190.77x	95.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	3.08x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	-20.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	216.5%
Profitability
Gross Margin (TTM)	0.0%	36.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-33M
FCF (TTM)	$-19M	$-14M
EPS (TTM)	-$1.83	-$21.10
ROE (TTM)	-16571.0%	-44308.0%
ROA (TTM)	-11542.0%	-31311.0%
ROIC (TTM)	-16571.0%	-44308.0%
Financial Health
Cash	$34M	$5M
Debt	$0	$0
Net Cash/Debt	$34M	$5M
Current Ratio (TTM)	6.66x	2.61x
Quick Ratio (TTM)	6.49x	2.51x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.81
52W Performance	-69.7%	-75.3%
YTD Performance	-58.2%	-67.3%
% from 52W High	-71.4%	-76.8%
% from 52W Low	8.2%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.08x
FCF Yield (TTM)	-168.2%	-4.9%
Earnings Yield (TTM)	-192.7%	-11.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View GTBP research